Milestone Scientific Cash Flow from Investing Activities 2010-2023 | MLSS

Milestone Scientific cash flow from investing activities from 2010 to 2023. Cash flow from investing activities can be defined as the total change in cash resulting from a companies investments
Milestone Scientific Annual Cash Flow Investing
(Millions of US $)
2023 $-3
2022 $-0
2021 $-0
2020 $-0
2019 $-0
2018 $-0
2017 $-0
2016 $0
2015 $-4
2014 $-1
2013 $-1
2012 $-0
2011 $-0
2010 $-0
2009 $-0
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $0.051B $0.010B
Milestone Scientific, Inc. develops, manufactures, markets and sells equipment and related disposable or consumable items and other products for use primarily by the dental practitioner. The company's principal product is ``The Wand(TM)``, a computer controlled ``painless`` injection system enabling the practitioner to more quickly and effectively anesthetize patients in certain dental applications. The company also markets and sells: ``SplatrFree(TM)`` disposable prophy angles and related consumable products; and clinically oriented dental products.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $71.435B 19.83
Becton Dickinson (BDX) United States $67.506B 19.10
West Pharmaceutical Services (WST) United States $26.709B 47.87
Cardinal Health (CAH) United States $23.733B 13.57
Align Technology (ALGN) United States $20.601B 39.78
Cooper (COO) United States $18.284B 27.67
Labcorp (LH) United States $16.996B 14.63
Henry Schein (HSIC) United States $9.348B 16.57
DENTSPLY SIRONA (XRAY) United States $5.774B 14.95
Merit Medical Systems (MMSI) United States $4.597B 25.19
Patterson (PDCO) United States $2.318B 11.10
CONMED (CNMD) United States $2.138B 19.39
STAAR Surgical (STAA) United States $2.015B 77.40
Atrion (ATRI) United States $0.722B 37.19
Lifevantage (LFVN) United States $0.084B 10.89
Pro-Dex (PDEX) United States $0.064B 32.24
Biolase (BIOL) United States $0.006B 0.00